Nectar Lifesciences informs about outcome of board meeting

11 Feb 2020 Evaluate

Nectar Lifesciences  has informed that the Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone & Consolidated Financial results for the quarter and nine months ended on December 31, 2019, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

41.44 -0.84 (-1.99%)
23-Dec-2024 15:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1812.75
Dr. Reddys Lab 1341.25
Cipla 1474.00
Lupin 2157.00
Zydus Lifesciences 971.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.